To the Editor, The exact time to stop bladder cancer patient's follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the timing of follow-up, and there is currently no real consensus on optimal time schedule [...]
To access publisher's full text version of this article click on the hyperlink belowOBJECTIVE: In n...
Bladder cancer is a relatively common type of CA that most often arises in urothelilal cells lining ...
Objectives: Intravesical chemotherapy has been studied in randomized clinical trials for >30 yr; how...
Rationale: Several guidelines exist that address treatment of patients with nonmetastatic muscle-inv...
Several guidelines exist that address treatment of patients with nonmetastatic muscle-invasive bladd...
Item does not contain fulltextPURPOSE OF REVIEW: Goal of surveillance after curative treatment of bl...
OBJECTIVE: Non-muscle-invasive bladder cancer (NMIBC) comprises a wide spectrum of tumors with diffe...
International audienceINTRODUCTION:Cancer Committee of the French Association of Urology (CCAFU) con...
INTRODUCTION: Data from single-center series suggest that a delay in time to radical cystectomy (RC)...
PURPOSE OF REVIEW: Patients with nonmuscle invasive bladder cancer (NMIBC) have a high risk of recur...
AIMS & OBJECTIVES: 1. To study the incidence of bladder tumour recurrence at three months followin...
Objective: In non-muscle-invasive bladder cancer (NMIBC), local recurrence after transurethral resec...
CONTEXT: Surveillance of the urethra and management of urethral recurrence (UR) after radical cystec...
Context: Surveillance of the urethra and management of urethral recurrence (UR) after radical cystec...
Context: Invasive bladder cancer is a frequently occurring disease with a high mortality rate despi...
To access publisher's full text version of this article click on the hyperlink belowOBJECTIVE: In n...
Bladder cancer is a relatively common type of CA that most often arises in urothelilal cells lining ...
Objectives: Intravesical chemotherapy has been studied in randomized clinical trials for >30 yr; how...
Rationale: Several guidelines exist that address treatment of patients with nonmetastatic muscle-inv...
Several guidelines exist that address treatment of patients with nonmetastatic muscle-invasive bladd...
Item does not contain fulltextPURPOSE OF REVIEW: Goal of surveillance after curative treatment of bl...
OBJECTIVE: Non-muscle-invasive bladder cancer (NMIBC) comprises a wide spectrum of tumors with diffe...
International audienceINTRODUCTION:Cancer Committee of the French Association of Urology (CCAFU) con...
INTRODUCTION: Data from single-center series suggest that a delay in time to radical cystectomy (RC)...
PURPOSE OF REVIEW: Patients with nonmuscle invasive bladder cancer (NMIBC) have a high risk of recur...
AIMS & OBJECTIVES: 1. To study the incidence of bladder tumour recurrence at three months followin...
Objective: In non-muscle-invasive bladder cancer (NMIBC), local recurrence after transurethral resec...
CONTEXT: Surveillance of the urethra and management of urethral recurrence (UR) after radical cystec...
Context: Surveillance of the urethra and management of urethral recurrence (UR) after radical cystec...
Context: Invasive bladder cancer is a frequently occurring disease with a high mortality rate despi...
To access publisher's full text version of this article click on the hyperlink belowOBJECTIVE: In n...
Bladder cancer is a relatively common type of CA that most often arises in urothelilal cells lining ...
Objectives: Intravesical chemotherapy has been studied in randomized clinical trials for >30 yr; how...